0001929743-22-000001.txt : 20220520 0001929743-22-000001.hdr.sgml : 20220520 20220520153143 ACCESSION NUMBER: 0001929743-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220520 DATE AS OF CHANGE: 20220520 EFFECTIVENESS DATE: 20220520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Acanna Therapeutics, Inc. CENTRAL INDEX KEY: 0001929743 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-446471 FILM NUMBER: 22947360 BUSINESS ADDRESS: STREET 1: 4851 TAMIAMI TRAIL N STREET 2: SUITE 200 CITY: NAPLES STATE: FL ZIP: 34103 BUSINESS PHONE: 403-605-8747 MAIL ADDRESS: STREET 1: 4851 TAMIAMI TRAIL N STREET 2: SUITE 200 CITY: NAPLES STATE: FL ZIP: 34103 D 1 primary_doc.xml X0708 D LIVE 0001929743 Acanna Therapeutics, Inc. 4851 TAMIAMI TRAIL N SUITE 200 NAPLES FL FLORIDA 34103 403-605-8747 DELAWARE None None Corporation true 2022 Joseph Tucker 4851 Tamiami Trail North Naples FL FLORIDA 34103 Executive Officer Director Chief Executive Officer Other Health Care Decline to Disclose 06b false 2022-05-05 true true true true false 0 Palladium Capital Group, LLC 129400 Michael Hartstein 4058428 152 West 57th Street Floor 22 New York NY NEW YORK 10019 NY NEW YORK false 5000000 1000000 4000000 false 1 450000 true 0 Commission will be paid to Palladium Capital Group, LLC in convertible preferred stock and warrants of the issuer. Palladium will also receive warrants for common stock equal to 8% of the common stock issuable upon conversion of the Preferred Stock. 0 false Acanna Therapeutics, Inc. /s/ Joseph Tucker Joseph Tucker Chief Executive Officer and Director 2022-05-20